Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 17 studies | 49% ± 16% | |
endothelial cell | 15 studies | 27% ± 10% | |
endothelial cell of vascular tree | 8 studies | 22% ± 3% | |
vein endothelial cell | 7 studies | 25% ± 4% | |
epithelial cell | 4 studies | 25% ± 7% | |
capillary endothelial cell | 4 studies | 22% ± 6% | |
fibroblast | 4 studies | 30% ± 8% | |
basal cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of SHC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 5306.96 | 359 / 359 | 100% | 67.37 | 286 / 286 |
esophagus | 100% | 6603.84 | 1444 / 1445 | 100% | 92.51 | 183 / 183 |
lung | 100% | 9625.19 | 578 / 578 | 100% | 104.69 | 1153 / 1155 |
ovary | 100% | 6210.94 | 180 / 180 | 100% | 71.95 | 429 / 430 |
skin | 100% | 10773.89 | 1809 / 1809 | 100% | 183.89 | 470 / 472 |
breast | 100% | 12314.53 | 459 / 459 | 99% | 92.63 | 1111 / 1118 |
intestine | 100% | 6275.15 | 966 / 966 | 99% | 65.45 | 523 / 527 |
bladder | 100% | 8134.90 | 21 / 21 | 98% | 83.12 | 496 / 504 |
uterus | 100% | 7990.64 | 170 / 170 | 97% | 83.06 | 447 / 459 |
thymus | 100% | 8520.49 | 653 / 653 | 97% | 66.47 | 589 / 605 |
prostate | 100% | 8208.59 | 245 / 245 | 96% | 52.99 | 481 / 502 |
adrenal gland | 100% | 9228.92 | 258 / 258 | 96% | 222.59 | 220 / 230 |
kidney | 100% | 5390.74 | 89 / 89 | 95% | 68.18 | 856 / 901 |
pancreas | 95% | 2813.79 | 311 / 328 | 98% | 80.17 | 174 / 178 |
liver | 97% | 4537.74 | 220 / 226 | 95% | 78.65 | 386 / 406 |
brain | 58% | 1312.72 | 1522 / 2642 | 77% | 31.49 | 540 / 705 |
adipose | 100% | 12592.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8368.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 6558.55 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.43 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 74.42 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 96% | 62.23 | 43 / 45 |
heart | 95% | 3799.43 | 817 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 2986.40 | 744 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 2124.79 | 777 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 30.02 | 21 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0007507 | Biological process | heart development |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0042742 | Biological process | defense response to bacterium |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005886 | Cellular component | plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0070435 | Cellular component | Shc-EGFR complex |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005158 | Molecular function | insulin receptor binding |
GO_0005159 | Molecular function | insulin-like growth factor receptor binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0046875 | Molecular function | ephrin receptor binding |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0048408 | Molecular function | epidermal growth factor binding |
GO_0005068 | Molecular function | transmembrane receptor protein tyrosine kinase adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
GO_0005168 | Molecular function | neurotrophin TRKA receptor binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | SHC1 |
Protein name | SHC adaptor protein 1 SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1) SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) |
Synonyms | SHCA SHC |
Description | FUNCTION: Signaling adapter that couples activated growth factor receptors to signaling pathways. Participates in a signaling cascade initiated by activated KIT and KITLG/SCF. Isoform p46Shc and isoform p52Shc, once phosphorylated, couple activated receptor tyrosine kinases to Ras via the recruitment of the GRB2/SOS complex and are implicated in the cytoplasmic propagation of mitogenic signals. Isoform p46Shc and isoform p52Shc may thus function as initiators of the Ras signaling cascade in various non-neuronal systems. Isoform p66Shc does not mediate Ras activation, but is involved in signal transduction pathways that regulate the cellular response to oxidative stress and life span. Isoform p66Shc acts as a downstream target of the tumor suppressor p53 and is indispensable for the ability of stress-activated p53 to induce elevation of intracellular oxidants, cytochrome c release and apoptosis. The expression of isoform p66Shc has been correlated with life span (By similarity). Participates in signaling downstream of the angiopoietin receptor TEK/TIE2, and plays a role in the regulation of endothelial cell migration and sprouting angiogenesis. . |
Accessions | ENST00000414115.5 Q5T188 ENST00000444179.5 H0Y539 ENST00000368450.5 [P29353-2] Q5T181 ENST00000368445.9 [P29353-1] X6R6D0 P29353 ENST00000368449.8 Q5T182 ENST00000366442.2 ENST00000448116.7 [P29353-6] Q5T187 ENST00000368453.8 [P29353-7] ENST00000444664.5 ENST00000412170.5 |